Translational neurorehabilitation research in the third world: what barriers to trial participation can teach us.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 24643406.
- Also identified by DOI 10.1161/STROKEAHA.113.003572 and PMC identifier 4045412.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most stroke rehabilitation studies have been performed in high-income countries. The aim of this study was to identify the main barriers for patient inclusion in a research protocol performed in Brazil. We evaluated reasons for exclusion of patients in a pilot, randomized, double-blinded clinical trial of stroke rehabilitation. Descriptive statistical analysis was performed. Only 5.6% of 571 screened patients were included. Recurrent stroke was responsible for exclusion of 45.4% of potentially eligible patients. Recurrent stroke represented a big barrier to enroll patients in the protocol. External validity of rehabilitation trials will benefit from definition of study criteria according to regional characteristics of patients, including rates of recurrent stroke. http://www.clinicaltrials.gov. Unique identifier: NCT01333579.
Medical subject headings
- Clinical Trials as Topic
- Patient Selection
- Stroke Rehabilitation
- Translational Research, Biomedical